首页|缺血性脑卒中二级预防药物依从性与疾病复发的关系研究

缺血性脑卒中二级预防药物依从性与疾病复发的关系研究

扫码查看
目的 本研究旨在探讨二级预防药物依从性现状及其与缺血性脑卒中复发之间的关系.方法 200 例缺血性脑卒中患者作为研究对象,收集其一般资料及相关指标,随访 6 个月,调查他汀类药物、抗血小板聚集药物等使用情况,采用Morisky用药依从性问卷(MMAS-8)分析药物依从性,并分析二级预防药物依从性与缺血性脑卒中复发的关系.结果 收集患者 200 例,失访 21 例,纳入 179 例,其中伴高血压患者 106 例、2 型糖尿病患者 62 例,他汀类药物依从性良好 112 例,占 62.57%,依从性差67 例,占 37.43%;抗血小板聚集药物依从性良好 126 例,70.39%,依从性差 53 例,占 29.61%;降压药物依从性良好 59 例,77.63%,依从性差 17 例,占 22.37%;降糖药物依从性良好 39 例,占 76.47%,依从性差 12 例,占 23.53%.排除单纯降压药依从性差 11 例、降糖药物依从性差 6 例、同时两种药物依从性差 6 例,剩余 156 例患者中,他汀类药物依从性好患者 101 例,复发 9 例,占比 8.91%;依从性差患者55 例,复发 17 例,占比 30.91%.他汀类药物依从性差患者的缺血性脑卒中复发率明显高于依从性良好患者,且具有显著差异(P<0.001).抗血小板聚集药物依从性良好患者 112 例,复发 7 例,占比 6.25%;依从性差患者 44 例,复发 19 例,占比 43.18%.抗血小板聚集药物依从性差患者的缺血性脑卒中复发率明显高于依从性良好患者,且具有显著差异(P<0.001).根据二级预防药物常见依从性差原因设置问题选项,结果显示检查指标正常后自行停药、症状改善后自行停药为主要原因,其次为经济原因、不良反应等.结论 缺血性脑卒中患者存在药物使用依从性差的问题,且依从性越差,缺血性脑卒中复发率越高,表明缺血性脑卒中二级预防药物依从性与复发之间存在密切关联.
Study on the correlation between adherence to secondary prevention drugs and disease recurrence in ischemic stroke
Objective To explore the correlation between adherence to secondary prevention drugs and disease recurrence in ischemic stroke.Methods 200 patients with ischemic stroke were included as the research subjects.General data and related indicators were collected,followed up for 6 months to investigate the use of secondary preventive drugs and antiplatelet aggregation.Morisky medication adherence questionnaire(MMAS-8)was used to analyze drug compliance,and the correlation between adherence to secondary preventive drug and ischemic stroke recurrence was analyzed.Results A total of 200 patients were collected,21 cases were lost to follow-up,and 179 cases were included,including 106 patients with hypertension and 62 patients with type 2 diabetes mellitus.112 cases with good adherence to statins,accounting for 62.57%,and 67 cases with poor adherence,accounting for 37.43%;126 cases with good adherence to antiplatelet aggregation drugs,accounting for 70.39%,and 53 cases with poor adherence,accounting for 29.61%;59 cases with good adherence to antihypertensive drugs,accounting for 77.63%,and 17 cases with poor compliance,accounting for 22.37%;39 cases with good adherence to hypoglycemic drugs,accounting for 76.47%,and 12 cases with poor compliance,accounting for 23.53%.Excluding 11 cases of poor adherence to antihypertensive drugs alone,6 cases of poor adherence to hypoglycemic drugs,and 6 cases of poor adherence to both drugs,among the remaining 156 patients,there were 101 patients with good adherence to statins,with 9 cases of recurrence,accounting for 8.91%,and 55 patients with poor adherence,with 17 cases of recurrence,accounting for 30.91%.The recurrence rate of ischemic stroke in patients with poor adherence to statins was significantly higher than that in patients with good adherence,and there was a significant difference(P<0.001).There were 112 patients with good adherence to antiplatelet aggregation drugs,with 7 cases of recurrence,accounting for 6.25%;44 patients with poor adherence,with 19 cases of recurrence,accounting for 43.18%.The recurrence rate of ischemic stroke in patients with poor adherence to antiplatelet aggregation drugs was significantly higher than that in patients with good adherence,and there was a significant difference(P<0.001).The question options were set according to the common reasons for poor adherence to secondary prevention drugs,and the results showed that the main reasons were self-withdrawal after normal examination indicators and self-withdrawal after improvement of symptoms,followed by economic reasons and adverse reactions.Conclusion There is a problem of poor adherence to secondary prevention drugs in patients with ischemic stroke,and the lower the adherence,the higher the recurrence rate of ischemic stroke.This indicates a significant correlation between adherence to secondary prevention drugs and the recurrence of ischemic stroke.

Ischemic strokeRecurrenceAdherence to secondary prevention drugsCorrelation

叶明、时鹏、张丽娜、许娟娟、罗文平

展开 >

233004 蚌埠医学院第一附属医院神经内科

缺血性脑卒中 复发 二级预防药物依从性 关系

蚌埠医学院人文社会科学研究重点项目

2022byzd125sk

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(10)
  • 10